Search Results - "Kagita, Sailaja"
-
1
Role of Antioxidant Gene Polymorphisms in Risk and Prognosis of Chronic Myeloid Leukemia
Published in Asian Pacific journal of cancer biology (21-03-2021)“…Introduction: We aimed to investigate the possible role of antioxidant enzyme polymorphisms CAT -21A/T (rs7943316), CAT -262C/T (rs1001179), GPX1 -198C/T…”
Get full text
Journal Article -
2
Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia
Published in Japanese journal of clinical oncology (01-08-2015)“…Altered differentiation is a common feature of haematopoietic malignancies with poor prognosis. CAAT/enhancer binding protein alpha (C/EBPα) is a key…”
Get full text
Journal Article -
3
Incidence of internal tandem duplications and D835 mutations of FLT3 gene in chronic myeloid leukemia patients from Southern India
Published in Hematology (Luxembourg) (01-04-2014)“…To screen two important FLT3 mutations (internal tandem duplication (ITD) and D835 point mutations) in chronic myeloid leukemia (CML) patients from Southern…”
Get more information
Journal Article -
4
Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India
Published in Asian Pacific journal of cancer prevention : APJCP (2016)“…Background: Development of chronic myeloid leukemia (CML) involves formation of double strand breaks (DSBs) which are initially sensed by the ataxia…”
Get full text
Journal Article -
5
Role of the MDM2 Promoter Polymorphism (-309T>G) in Acute Myeloid Leukemia Development
Published in Asian Pacific journal of cancer prevention : APJCP (2015)“…Background: The human homologue of the mouse double minute 2 (MDM2) gene is a negative regulator of Tp53. MDM2-309T>G a functional promoter polymorphism was…”
Get full text
Journal Article -
6
Influence of Caspase-9 polymorphisms on the development of Chronic Myeloid Leukemia- A case-control study
Published in Gene (01-01-2019)“…Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder, characterized by the overproduction of myeloid cells in all stages of maturation. It is…”
Get full text
Journal Article -
7
Impact of polymorphisms of TP53 Arg72Pro, excision repair cross-complementing Protein 1 Asn118Asn (C118T) and deletion in Intron 2 of BIM in chronic myeloid leukemia patients on imatinib treatment
Published in Journal of natural science, biology and medicine (01-07-2018)“…Background: Imatinib (IM) results in durable responses in a large number of patients with chronic myeloid leukemia (CML). However, a substantial number…”
Get full text
Journal Article -
8
A Rare Toxicity to Chemotherapy
Published in Journal of pharmacology & pharmacotherapeutics (01-01-2020)“…The use of chemotherapy is often limited by toxic side-effects caused to healthy cells. In general, most chemotherapy treatments cause DNA damage or stop cells…”
Get full text
Journal Article -
9
Abstract 3858: Genetic polymorphisms of DNA repair genes in the origin and progression of chronic myeloid leukemia
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Background: The origin of Chronic Myeloid Leukaemia (CML) involves the formation of Double Strand Breaks (DSBs) which are initially sensed by the…”
Get full text
Journal Article -
10
Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India
Published in Tumor biology (01-07-2014)“…Mutations in the Bcr-Abl kinase domain (KD) are a major cause for acquired resistance to imatinib (IM) treatment and have been associated with progression and…”
Get full text
Journal Article -
11
Assessment of BCR-ABL1 fusion transcripts and their association with response to imatinib treatment in chronic myeloid leukemia patients
Published in Indian journal of medical and paediatric oncology (01-04-2018)“…Objectives: BCR-ABL1 fusion transcripts with contrasting data on response to imatinib therapy have been reported from different parts of the world. Hence, the…”
Get full text
Journal Article -
12
Methylation status of CEBPA gene promoter in chronic myeloid leukemia
Published in Hematology (Luxembourg) (01-01-2014)“…CCAAT/enhancer binding protein alpha is one of the crucial transcription factors for myeloid cell development that has been found to be involved in…”
Get more information
Journal Article -
13
Association of XRCC5 VNTR polymorphism with the development of chronic myeloid leukemia
Published in Tumor biology (01-02-2014)“…Double-strand breaks (DSBs) inducing agents influence the fidelity of DNA repair in both normal cells and leukemic cells, causing major genomic instability. In…”
Get full text
Journal Article -
14
Association of promoter polymorphisms of Fas –FasL genes with development of Chronic Myeloid Leukemia
Published in Tumor biology (01-04-2016)“…Chronic myeloid leukemia (CML) is a monoclonal myeloproliferative disorder of hematopoietic stem cells (HSCs), characterized by reciprocal translocation,…”
Get full text
Journal Article -
15
Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India
Published in Hematology (Luxembourg) (01-05-2013)“…Chronic myeloid leukemia (CML), a clonal myeloproliferative disorder, is characterized primarily by the presence of chimeric BCR-ABL oncogene, and its…”
Get more information
Journal Article -
16
Association of thymidylate synthase 5'-UTR 28bp tandem repeat and serine hydroxymethyltransfarase C1420T polymorphisms with susceptibility to acute leukemia
Published in Asian Pacific journal of cancer prevention : APJCP (01-01-2014)“…The current study was aimed to elucidate the association of thymidylate synthase (TYMS) 5'- UTR 28bp tandem repeat and cytosolic serine…”
Get full text
Journal Article -
17
Early molecular response in chronic myeloid leukemia patients predicts future response status
Published in Tumor biology (01-05-2014)“…Imatinib is the frontline therapy for chronic myeloid leukemia (CML) management. Most of the CML patients achieve major responses, but a proportion (nearly…”
Get full text
Journal Article -
18
Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India
Published in Asian Pacific journal of cancer prevention : APJCP (07-03-2016)Get full text
Journal Article -
19
Outcomes of Ewing’s sarcoma: Real-world scenario from the developing world—An 11-year analysis
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
20
Role of the MDM2 Promoter Polymorphism (-309T>G) in Acute Myeloid Leukemia Development
Published in Asian Pacific journal of cancer prevention : APJCP (14-04-2015)Get full text
Journal Article